Search
Close this search box.

Freshwater bacteria’s vulnerability to climate change due to limited adaptability

Freshwater bacteria play a crucial role in the health and functioning of aquatic ecosystems. These microscopic organisms are responsible for...

Basal stem rot disease, caused by the fungus Ganoderma boninense, is a major threat to the oil palm industry worldwide....

A Texas-based lithium recovery firm has recently announced that they have licensed seven inventions from the Oak Ridge National Laboratory...

Nanotechnology has revolutionized various industries by enabling the manipulation of materials at the atomic and molecular scale. Nanomaterials, which are...

The Treasury Department and the Internal Revenue Service (IRS) have recently released updated guidance on the sustainable aviation fuel tax...

Caterbot and Robatapillar are two popular robotic devices that have gained attention for their ability to navigate loops and bends...

Arthritis is a common condition that affects millions of people worldwide. It is characterized by inflammation and stiffness in the...

A new study has shed light on the groundbreaking work of an 11th century Arab-Muslim optical scientist, whose contributions to...

The Society for Cardiovascular Angiography and Interventions (SCAI) has announced that Dr. James B. Hermiller, MD, MSCAI, has been appointed...

When it comes to understanding the softness of amorphous materials, one key factor that plays a significant role is the...

Plants are an essential part of our ecosystem, providing oxygen, food, and habitat for countless organisms. But have you ever...

The i3c BRIC-RCB Ph.D. Programme in Biosciences is now accepting applications for the upcoming academic year. This prestigious program, a...

Insilico Medicine, a leading artificial intelligence (AI) drug discovery company, has recently announced that it will be moving its headquarters...

Swiss pharmaceutical giant Novartis recently announced a major investment in a partnership with German biotech company MorphoSys, totaling $3 billion....

Sylvester Cancer Institute, a leading cancer treatment center in Miami, Florida, is at the forefront of incorporating cellular therapy in...

Sylvester Cancer, a leading cancer research and treatment center, is making strides in the fight against metastatic cancer by incorporating...

A recent study conducted by marine biologists has revealed an interesting finding about baby sharks – they prefer staying closer...

In recent years, the healthcare industry has seen a significant shift towards the use of artificial intelligence (AI) to improve...

Organ-on-chips, also known as microphysiological systems, are a cutting-edge technology that has been gaining traction in various industries in recent...

Autonomix Medical Inc. is making waves in the medical industry with its innovative nerve treatment technology, as highlighted in a...

In the pharmaceutical industry, ensuring compliance with regulations and guidelines is of utmost importance. One critical aspect of compliance is...

Sugar processing is a crucial step in the production of various sweeteners and food products. The efficiency of this process...

Studies Study First Submitted Date 2019-03-27 Study First Posted Date 2019-03-29 Last Update Posted Date 2023-04-19 Start Month Year April...

Sanofi, the pharmaceutical company behind the popular heartburn medication Zantac, has reached a resolution in the majority of lawsuits filed...

India has taken a significant step forward in the field of healthcare with the launch of its first home-grown gene...

The Brain & Behavior Research Foundation is a leading non-profit organization dedicated to funding cutting-edge research on mental health disorders....

Biotech Land is a leading company in the field of biotechnology, specializing in the development of innovative products derived from...

Biopharmaceutical companies are constantly seeking ways to improve the efficiency and effectiveness of their clinical trials. One emerging technology that...

In a groundbreaking development for the hemp industry, regulatory clearance has been granted for bioengineered hemp in the latest Bio.News...

Aardvark Therapeutics, a biotechnology company specializing in developing innovative treatments for rare diseases, is gearing up for a $200 million...

Cytomos to Showcase New Celledonia™ Technology at London Biotechnology Show 2024

Cytomos, a leading biotechnology company, is set to showcase its groundbreaking new technology, Celledonia™, at the upcoming London Biotechnology Show in 2024. This innovative technology promises to revolutionize the field of cell biology and has the potential to significantly impact various industries, including healthcare, pharmaceuticals, and research.

Celledonia™ is a cutting-edge platform that allows for the precise manipulation and analysis of individual cells. By combining advanced imaging techniques with state-of-the-art microfluidics, Cytomos has created a system that can isolate, culture, and study cells with unprecedented accuracy and efficiency. This technology opens up new possibilities for studying cellular processes, identifying disease mechanisms, and developing novel therapies.

One of the key features of Celledonia™ is its ability to perform high-throughput single-cell analysis. Traditional methods of studying cells often involve analyzing populations of cells, which can mask important differences between individual cells. With Celledonia™, researchers can study the behavior of each cell in a sample, providing a more detailed and comprehensive understanding of cellular processes.

In addition to its research applications, Celledonia™ also has significant potential in the field of personalized medicine. By analyzing individual cells from patients, doctors can tailor treatments to specific genetic profiles and disease characteristics, leading to more effective and targeted therapies. This personalized approach has the potential to revolutionize the way we treat diseases such as cancer, autoimmune disorders, and genetic conditions.

The London Biotechnology Show provides an ideal platform for Cytomos to showcase its new technology to a global audience of industry professionals, researchers, and investors. The company’s presence at the event is sure to generate significant interest and excitement within the biotechnology community.

Overall, Celledonia™ represents a major advancement in the field of cell biology and has the potential to drive innovation and discovery in a wide range of industries. As Cytomos prepares to unveil this groundbreaking technology at the London Biotechnology Show in 2024, the future looks bright for the field of biotechnology and the countless possibilities that lie ahead.